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Current guidance in the UK (1) (NICE guidelines) and 
the US (2) recommends the use of coronary artery bypass 
grafting (CABG) in the treatment of anatomically complex 
triple vessel disease. The UK also prefers CABG for the 
treatment of coronary artery disease in those >65 and 
those with diabetes (1), whilst the US recommends a heart 
team approach (2). Having made the decision to operate 
the next question that arises is whether to perform this 
with (on pump) or without (off pump) cardiopulmonary 
bypass. The attraction of off pump CABG is a reduction in 
the inflammatory response in combination with minimal 
aortic manipulation and avoidance of aortic cannulation, 
which may reduce the risk of stroke (3). However, many 
surgeons would argue that cardioplegic arrest provides the 
best conditions for optimal revascularisation (3,4). The 
debate as to which method is superior has been ongoing 
for the past 25 years.
There have been several meta-analyses that have pooled 
data from the numerous randomised clinical trials (RCTs) 
that have been conducted. A comprehensive Cochrane 
review published in 2012 reported that all-cause mortality 
was significantly increased in the off pump group whilst 
there were no differences in the incidence of myocardial 
infarction, stroke, renal insufficiency and coronary re-
intervention (5). Since that time more RCTs have been 
conducted and this year there has been three fresh 
investigations of the data. Kowalewski et al. showed that 
there was a significant 28% reduction in the incidence of 
stroke in the off pump group, which was related to patient 
risk profile (6). Deppe et al. also found a reduced incidence 
of stroke in the off pump group, whilst this group also had 
an increased need for revascularisation (4). The latest meta-
analysis by Dieberg et al. reported a P value of 0.05 for the 
stroke comparison and only found a significant difference in 
the incidence of atrial fibrillation (7). Two limitations that 
affect each of these studies are the small size of many of the 
included RCTs and a concentration on short term (30 days) 
outcomes (4-7).
The four largest trials to date are CORONARY 
(n=2,375 off vs. 2,377 on) (8); DOORS (n=450 off vs. 450 
on) (9); GOPCABE (n=1,271 off vs. 1,268 on) (10) and 
ROOBY (n=1,104 off vs. 1,099 on) (11). None of these 
studies showed a significant difference in the occurrence 
of death or stroke at or within 30 days of surgery (8-11) 
and the same was true for the incidence of myocardial 
infarction in CORONARY, DOORS and GOPCABE 
(8-10). A significantly higher early need for repeat 
revascularisation in the off pump group was measured in 
CORONARY and GOPCABE (8,10), whereas ROOBY 
measured no difference in the rate of repeat cardiac 
surgery (11). In short none of these major studies showed 
a difference in hard clinical outcomes between the off and 
on pump groups at 30 days.
Clearly answering the question of whether to operate 
off or on pump depends not only on 30 days outcomes but 
also on what happens in the longer term. Unfortunately, 
relatively few authors have published follow ups to their 
studies. For example, Luo et al. in their 2015 meta-analysis 
of RCTs with >6 months follow up only synthesised 
the results of four studies for mortality and only three 
King. On vs. off pump
© Annals of Translational Medicine. All rights reserved. Ann Transl Med 2017;5(5):116atm.amegroups.com
Page 2 of 3
studies for incidence of myocardial infarction, stroke and 
revascularisation (12). Some caution might therefore be 
advised in the interpretation of the results. Nevertheless, 
the synthesised results showed that there was no difference 
in the incidence of mortality, myocardial infarction and 
stroke between the two groups; however, there was a 
significantly higher rate of revascularisation in the off pump 
group (12). It is noteworthy that the single 6 months follow 
up and the two 1-year follow ups discussed in this meta-
analysis were from three of the large RCTs mentioned 
above (CORONARY, DOORS and GOPCABE) (12). It 
should also be noted that Luo et al. missed at least one 
study, namely that of Angelini et al. who pooled the follow 
up (1–3 years) results of two of their RCTs (13). The latter 
found no significant differences in the occurrence of cardiac 
or non-cardiac related events between the two groups (13). 
This included no significant difference in the number of 
patients who needed repeat cardiac catheterization (13).
One of the factors that predisposes to improved long-
term survival is completeness of revascularisation, and a 
surrogate for this is the number of grafts placed (Adrian 
Marchbank, personal communication). In each of the four 
largest trials a significantly greater number of grafts were 
placed in the on pump group, although the difference 
in the number of grafts placed in each group was only 
0.1–0.2 grafts (8-11). The CORONARY trial also reported 
the completeness of revascularisation where 278 patients 
were incompletely revascularised in the off pump group 
compared to 236 in the on pump group (P=0.05) (8). In 
spite of this mortality in the CORONARY study was not 
significantly different between the off and on pump groups 
at 30 days (8) and 1 year (14).
The paucity of follow up reporting, particularly 
regarding long term outcomes,  makes the recent 
publication of the 5-year outcomes of the CORONARY 
trial very important (15). This was easily the largest of 
the RCTs to date, which enrolled a total of 4,752 patients 
from 79 hospitals in 19 different countries (8). There was 
very good matching of baseline characteristics including 
age, gender, clinical history, left ventricular ejection factor, 
and EuroSCORE grade (8). The primary outcome at 
30 days was a composite of death, nonfatal stroke, nonfatal 
myocardial infarction and new renal failure. The results 
showed that there was no significant difference in the 
occurrence of the composite nor in any of its individual 
elements between the off and on pump groups (8) and 
this continued to be the case at 1 year (14). At the early 
time point significantly more of the off pump group had 
required revascularisation compared to the on pump 
group; however, by the time 1 year had passed this 
difference had disappeared (14). Revascularisation was also 
amongst the outcomes analysed in the 5-year follow up 
alongside death, stroke, myocardial infarction and renal 
failure. In addition, Lamy et al. (15) also investigated cost 
and quality of life. There were no significant differences 
in the off compared to on pump group in any of the 
measured parameters. The authors do refer to four studies 
that have shown higher long term mortality or greater 
repeat revascularisation in the off pump group; however, 
all of these comparator studies were retrospective reviews 
of patient notes (15).
To date the CORONARY trial is the largest RCT 
comparing off pump vs. on pump CABG. It is also the 
only sizable trial to follow its participants through to 
5-year post-operation, although a 6–8 years follow up in 
the pooled results of two small RCTs is noted (16). The 
CORONARY trial has consistently shown that there was 
no significant difference in hard clinical outcomes following 
either off or on pump CABG at 30 days, 1 year and 5 years 
post-operation. Consequently, with no hard clinical data 
in favour of one approach or the other, the decision as to 
whether to operate off or on pump may simply come down 
to the individual surgeon’s preference.
Acknowledgements
The author would like to thank Dr. Adrian Marchbank for 
his clinical expertise.
Footnote
Conflicts of Interest: The author has no conflicts of interest to 
declare.
References
1. NICE. Stable angina: management. Clinical guideline 
[CG126]. Available online: https://www.nice.org.uk/
guidance/cg126/chapter/1-Guidance#investigation-and-
revascularisation
2. Fihn SD, Blankenship JC, Alexander KP, et al. 2014 
ACC/AHA/AATS/PCNA/SCAI/STS focused update 
of the guideline for the diagnosis and management of 
patients with stable ischemic heart disease. Circulation 
2014;130:1749-67.
3. Fudulu D, Benedetto U, Pecchinenda GG, et al. Current 
Annals of Translational Medicine, Vol 5, No 5 March 2017 Page 3 of 3
© Annals of Translational Medicine. All rights reserved. Ann Transl Med 2017;5(5):116atm.amegroups.com
outcomes of off-pump versus on-pump coronary artery 
bypass grafting: evidence from randomized controlled 
trials. J Thorac Dis 2016;8:S758-S771.
4. Deppe AC, Arbash W, Kuhn EW, et al. Current evidence 
of coronary artery bypass grafting off-pump versus on-
pump: a systematic review with meta-analysis of over 
16,900 patients investigated in randomized controlled 
trials†. Eur J Cardiothorac Surg 2016;49:1031-41; 
discussion 1041.
5. Møller CH, Penninga L, Wetterslev J, et al. Off-pump 
versus on-pump coronary artery bypass grafting for 
ischaemic heart disease. Cochrane Database Syst Rev 
2012;(3):CD007224. 
6. Kowalewski M, Pawliszak W, Malvindi PG, et al. Off-
pump coronary artery bypass grafting improves short-term 
outcomes in high-risk patients compared with on-pump 
coronary artery bypass grafting: Meta-analysis. J Thorac 
Cardiovasc Surg 2016;151:60-77.e1-58.
7. Dieberg G, Smart NA, King N. On- vs. off-pump 
coronary artery bypass grafting: A systematic review and 
meta-analysis. Int J Cardiol 2016;223:201-11.
8. Lamy A, Devereaux PJ, Prabhakaran D, et al. Off-pump 
or on-pump coronary-artery bypass grafting at 30 days. N 
Engl J Med 2012;366:1489-97.
9. Houlind K, Kjeldsen BJ, Madsen SN, et al. On-pump 
versus off-pump coronary artery bypass surgery in elderly 
patients: results from the Danish on-pump versus off-
pump randomization study. Circulation 2012;125:2431-9. 
10. Diegeler A, Börgermann J, Kappert U, et al. Off-pump 
versus on-pump coronary-artery bypass grafting in elderly 
patients. N Engl J Med 2013;368:1189-98. 
11. Shroyer AL, Grover FL, Hattler B, et al. On-pump versus 
off-pump coronary-artery bypass surgery. N Engl J Med 
2009;361:1827-37. 
12. Luo T, Ni Y. Short-term and Long-term Postoperative 
Safety of Off-Pump versus On-Pump Coronary Artery 
Bypass Grafting for Coronary Heart Disease: A Meta-
analysis for Randomized Controlled Trials. Thorac 
Cardiovasc Surg 2015;63:319-27.
13. Angelini GD, Taylor FC, Reeves BC, et al. Early and 
midterm outcome after off-pump and on-pump surgery 
in Beating Heart Against Cardioplegic Arrest Studies 
(BHACAS 1 and 2): a pooled analysis of two randomised 
controlled trials. Lancet 2002;359:1194-9.
14. Lamy A, Devereaux PJ, Prabhakaran D, et al. Effects of 
off-pump and on-pump coronary-artery bypass grafting at 
1 year. N Engl J Med 2013;368:1179-88.
15. Lamy A, Devereaux PJ, Prabhakaran D, et al. Five-Year 
Outcomes after Off-Pump or On-Pump Coronary-Artery 
Bypass Grafting. N Engl J Med 2016;375:2359-68. 
16. Angelini GD, Culliford L, Smith DK, et al. Effects of on- 
and off-pump coronary artery surgery on graft patency, 
survival, and health-related quality of life: long-term 
follow-up of 2 randomized controlled trials. J Thorac 
Cardiovasc Surg 2009;137:295-303.
Cite this article as: King N. On vs. off pump coronary artery 
bypass grafting: the next chapter. Ann Transl Med 2017;5(5):116. 
doi: 10.21037/atm.2017.01.51
